NASDAQ:CYPH Cypherpunk Technologies (CYPH) Stock Price, News & Analysis $0.69 -0.05 (-6.78%) As of 12:06 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Cypherpunk Technologies Stock (NASDAQ:CYPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CYPH alerts:Sign Up Key Stats Today's Range$0.68▼$0.7250-Day Range$0.52▼$1.3152-Week Range$0.23▼$3.70Volume759,428 shsAverage Volume3.51 million shsMarket Capitalization$73.34 millionP/E RatioN/ADividend YieldN/APrice Target$0.90Consensus RatingModerate Buy Company Overview Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion. DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies. In addition to DKN-01, Cypherpunk is advancing preclinical programs that target novel pathways involved in cancer cell signaling and immune regulation, with the aim of identifying complementary assets for future clinical development. Founded in 2016 and headquartered in Irvine, California, Leap Therapeutics completed its initial public offering in 2019 and now trades on the NASDAQ under the ticker CYPH. The company conducts clinical trials in the United States and collaborates with academic and industry partners to accelerate its development programs. Michael Stoll, M.D., serves as President and Chief Executive Officer, overseeing a team of experienced professionals in oncology drug discovery and development. AI Generated. May Contain Errors. Read More Cypherpunk Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks32nd Percentile Overall ScoreCYPH MarketRank™: Cypherpunk Technologies scored higher than 32% of companies evaluated by MarketBeat, and ranked 1437th out of 1,682 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingCypherpunk Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Upside PotentialCypherpunk Technologies has a consensus price target of $0.90, representing about 21.8% upside from its current price of $0.74.Amount of Analyst CoverageCypherpunk Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Cypherpunk Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cypherpunk Technologies is -36.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cypherpunk Technologies is -36.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCypherpunk Technologies has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.47% of the float of Cypherpunk Technologies has been sold short.Short Interest Ratio / Days to CoverCypherpunk Technologies has a short interest ratio ("days to cover") of 3.13, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cypherpunk Technologies has recently increased by 9.95%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCypherpunk Technologies does not currently pay a dividend.Dividend GrowthCypherpunk Technologies does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Cypherpunk Technologies this week, compared to 2 articles on an average week.Search Interest1 people have searched for CYPH on MarketBeat in the last 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cypherpunk Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders3.50% of the stock of Cypherpunk Technologies is held by insiders.Percentage Held by Institutions30.46% of the stock of Cypherpunk Technologies is held by institutions.Read more about Cypherpunk Technologies' insider trading history. Receive CYPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cypherpunk Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYPH Stock News HeadlinesCypherpunk Technologies Faces Nasdaq Listing Compliance WarningJuly 21 at 4:51 PM | tipranks.comCypherpunk Technologies Reports First Quarter 2026 Financial ResultsMay 14, 2026 | prnewswire.comNNVC: FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles — a disease with no approved antiviral treatment currently on the market. NV-387 is designed as a broad-spectrum antiviral with potential applications across RSV, influenza, coronaviruses, Mpox, and more. With Phase II trials advancing and measles cases resurging globally, NNVC is entering a notable inflection point.July 22 at 1:00 AM | Equiscreen (Ad)Cypherpunk Increases its Zcash Stake, Launches New Website and Investor DashboardApril 15, 2026 | prnewswire.comCypherpunk Technologies Announces Planned Board Leadership TransitionsApril 12, 2026 | theglobeandmail.comCypherpunk Technologies (NASDAQ:CYPH) Stock, Option ChainApril 10, 2026 | benzinga.comCypherpunk Technologies Rocked by Major Insider Stock SaleMarch 30, 2026 | tipranks.comCypherpunk Reports Full Year 2025 Financial ResultsMarch 16, 2026 | prnewswire.comSee More Headlines CYPH Stock Analysis - Frequently Asked Questions How have CYPH shares performed this year? Cypherpunk Technologies' stock was trading at $1.16 at the start of the year. Since then, CYPH shares have decreased by 36.3% and is now trading at $0.7390. How were Cypherpunk Technologies' earnings last quarter? Cypherpunk Technologies (NASDAQ:CYPH) issued its quarterly earnings results on Thursday, May, 14th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by $0.42. When did Cypherpunk Technologies' stock split? Shares of Cypherpunk Technologies reverse split on the morning of Wednesday, June 21st 2023.The 1-10 reverse split was announced on Wednesday, June 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Cypherpunk Technologies? Shares of CYPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/14/2026Today7/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (7m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 CYPH's financial health is in the Yellow zone, according to TradeSmith. CYPH has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CYPH Previous SymbolNASDAQ:LPTX CIK1509745 Webwww.leaptx.com Phone(617) 714-0360FaxN/AEmployees40Year Founded2011Price Target and Rating Average Price Target for Cypherpunk Technologies$0.90 High Price Target$0.90 Low Price Target$0.90 Potential Upside/Downside+30.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$4.82 million Net MarginsN/A Pretax MarginN/A Return on Equity-48.33% Return on Assets-42.21% Debt Debt-to-Equity RatioN/A Current Ratio27.28 Quick Ratio27.28 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.83 per share Price / Book0.38Miscellaneous Outstanding Shares106,460,000Free Float102,738,000Market Cap$73.34 million OptionableOptionable Beta0.07 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:CYPH) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersThe smarter SpaceX play most investors will missOn July 1st, a brand-new blockchain went live. Traders flooded in. Memecoins launched by the hour. And accordi...Crypto 101 Media | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredOxford Club Analyst’s Urgent AI WarningAlexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...The Oxford Club | SponsoredNNVC: FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...Equiscreen | SponsoredElon says “don’t save money.” Is he right?Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal ...Freedom Financial | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredTrump’s emergency dollar resetBloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...Porter & Company | SponsoredYour First Trade Playbook is expiringMost beginners stay stuck on the sidelines for years because no one shows them the simple steps between being ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cypherpunk Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share Cypherpunk Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
